SEC FORM 4
$141,130.37
UNITED THERAPEUTICS Corp (UTHR)
Sale of 260 shares at $542.8091 per share.
Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S
Traded Oct 19, 2026 · Disclosed Oct 20, 2026
Source: SEC Form 4 · 0001106578-26-000167 · filed 2026-10-20 · View filing →